Imagine a tiny, high-tech lab-on-a-chip that mimics how human organs and fish embryos react to chemicals. Instead of testing on live animals, it uses sensors and computer models to predict if a substance is toxic in real-time. It's like a flight simulator for chemicals to see if they are safe before they ever hit the market.
Current chemical toxicity tests rely too heavily on animal testing and fail to mimic real-world exposure conditions. This leads to high development costs and late-stage failures when materials are found to be toxic only after significant investment.
A modular, plug-and-play toxicology testing device featuring microfluidic architecture, real-time sensors, and predictive computer models.
If you are a specialty chemical producer dealing with high costs and ethical hurdles of animal testing — this project developed a plug-and-play testing platform that identifies toxic compounds early in the development pipeline. This allows you to remove dangerous formulations before expensive trials.
If you are a nano-material developer dealing with unpredictable toxicity of 2D structures — this project developed a system validated using metallic 2D structures and nanoparticles. It provides reliable data on how these materials behave across different life cycle stages.
If you are an agrochemical company dealing with strict endocrine disruptor regulations — this project developed a device that mimics environmental conditions and uses zebrafish embryos. This ensures your new biocides meet safety standards before regulatory submission.
Based on available project data, the specific pricing or cost of the device is not mentioned.
The project focuses on a modular, plug-and-play instrument architecture designed for interlaboratory validation across 4 partners, suggesting a scalable design for different stakeholders.
Based on available project data, specific licensing terms are not provided, but a standardization folder will be prepared to make the device available for testing.
Yes, the system is designed to be validated against regulatory standards to support the Safe and Sustainable by Design (SSbD) approach and the Chemicals Strategy for Sustainability.
The platform enables real-time, non-invasive monitoring and early identification of toxic compounds, which speeds up the removal of failures from the pipeline.
The consortium is heavily weighted toward commercial application, with a 41% industry ratio comprising 7 industrial partners and 7 SMEs. This balance, combined with 4 universities and 5 research centers across 10 countries, indicates a strong push to move the technology from the lab into a standardized industrial tool.
Contact STEINBEIS 2I GMBH in Germany
Contact us to explore licensing opportunities for the TOXBOX modular platform.
